Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06747000 · ClinicalTrials.gov registry record
Lipoprotein Interactions and Platelet Function in Healthy Individuals and Those With Lipid Disorders
A clinical trial of Lipid Disorders, sponsored by The Miriam Hospital.
- Recruiting
- Registry status
- 80
- Enrollment target
- 2
- Study locations
NCT06747000: Recruiting study of Lipid Disorders, sponsored by The Miriam Hospital.
NCT06747000 is a study of Lipid Disorders that is actively recruiting participants, run by The Miriam Hospital. The registered enrollment target is 80 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06747000, a study of Lipid Disorders, is actively recruiting participants, sponsored by The Miriam Hospital.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study looks at how lipoproteins, which are particles in the blood that transport cholesterol, influence heart and blood vessel health. Beyond just their levels, the way these particles function plays a key role in preventing or contributing to disease. In some conditions, like high cholesterol or diabetes, lipoproteins may not work properly, increasing the risk of clogged arteries and other complications. The investigators aim to study these changes in people with lipid disorders to better understand their impact on blood health and to find new ways to prevent and treat heart disease.
Primary Outcome
Platelet aggregation area under the curve will be used as primary endpoint. Specifically, the percentage of platelet aggregation multiple time will be calculated to get area under the curve as a comprehensive marker for platelet aggregation response.
Conditions Studied
Study Locations (2)
Rhode Island
- Brown University Health Lipid Clinic - East Providence
- Cardiovascular Research Center - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-07-18 |
| Est. Completion | 2029-07-18 |
What NCT06747000 shows while recruiting
NCT06747000 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 1 condition, with Lipid Disorders appearing as the primary indexed condition, and to 0 interventions.
NCT06747000 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT06747000 about?
NCT06747000 is a clinical study titled "Lipoprotein Interactions and Platelet Function in Healthy Individuals and Those With Lipid Disorders". This study looks at how lipoproteins, which are particles in the blood that transport cholesterol, influence heart and blood vessel health. Beyond just their levels, the way these particles function plays a key role in preventing or contributing to disease. In some conditions, like high cholesterol ...
What is the current status of trial NCT06747000?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2024-07-18. Estimated completion is 2029-07-18.
What conditions does trial NCT06747000 study?
This clinical trial studies the following conditions: Lipid Disorders.
Who is sponsoring clinical trial NCT06747000?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06747000 being conducted?
This trial has 2 study locations across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI